Correction: Trifarotene Reduces Risk for Atrophic Acne Scars: Results from A Phase 4 Controlled Study
Dermatol Ther (Heidelb)
.
2024 Feb;14(2):559-561.
doi: 10.1007/s13555-023-01090-z.
Authors
Stephen Schleicher
1
,
Angela Moore
2
3
,
Elyse Rafal
4
,
Angelique Gagne-Henley
5
,
Sandra Marchese Johnson
6
,
Sunil Dhawan
7
,
Rajeev Chavda
8
,
J P York
9
,
Baldo Sforzolini
9
,
Kate Holcomb
10
,
Glynis Ablon
11
,
James Del Rosso
12
,
Brigitte Dreno
13
Affiliations
1
DermDox Centers for Dermatology, Sugarloaf, PA, USA.
2
Arlington Research Center, Inc, Arlington, TX, USA.
3
Baylor University Medical Center, Dallas, TX, USA.
4
DermResearchCenter of New York, Inc, Stony Brook, NY, USA.
5
Dr Angélique Gagné-Henley MD Inc, Saint-Jerome, Canada.
6
Johnson Dermatology, Fort Smith, AR, USA.
7
Center for Dermatology Clinical Research, Inc, Fremont, CA, USA.
8
Galderma SA, Lausanne, Switzerland.
[email protected]
.
9
Galderma Laboratories, Dallas, TX, USA.
10
H&H Research, Metairie, LA, USA.
11
Ablon Skin Institute & Research Center, University of California, Los Angeles, CA, USA.
12
JDR Research, Las Vegas, NV, USA.
13
Nantes University, CHU Nantes, France.
PMID:
38216821
PMCID:
PMC10891002
DOI:
10.1007/s13555-023-01090-z
No abstract available
Publication types
Published Erratum